Video

Paul S. Carbone, MD: A Challenging Time for Autism Patients

Author(s):

Dr. Carbone will present during AAP 2021 about managing autism in pediatric practices.

Better management for pediatric patients with autism spectrum disorder (ASD) is needed in the future.

Paul S. Carbone, MD, professor of pediatrics, University of Utah, explained in an interview with HCPLive® what gaps in autism management he believes can realistically be closed in the coming years in order to improve care for this patient population.

Carbone will present 2 presentations during the 2021 American Academy of Pediatrics Virtual Conference that focus on autism beyond diagnosis, specifically on managing the disease.

The session will include discussions on the current causes of autism and the appropriate medical workup, evidence-based treatments for autism, behavioral developmental interventions, complimentary alternative interventions, and how to make a practice more autism friendly.

Finally, the talk centers on the evaluation and management of co-occurring conditions.

Carbone said some of the most closeable gaps in autism management for general pediatricians is the co-occurring conditions, including insomnia, gastrointestinal conditions, and epilepsy, as well as other psychiatric conditions, such as ADHD, anxiety, and depression.

“Sometimes some of these co-occurring conditions, when they are not addressed can be a lot more disabling than the autism itself,” Carbone said.

He also said it is important to screen for some of the other diseases in order to improve care plans for patients. Finally, he said access to care must improve in the future to better care for minority patients who may have autism.

Related Videos
Rahul N. Khurana, MD: Phase 1 Results on Vamikibart for Uveitic Macular Edema | Image Credit: Northern California Retina Vitreous Associates
Sunir J. Garg, MD: | Image Credit: Wills Eye Hospital
James Del Rosso, DO: Discussing What’s New in the Medicine Chest for Dermatologists
What to Look Forward To at the Fall Clinical Dermatology Conference, with Raj Chovatiya, MD, PhD
Christine N. Kay, MD: Interim Data on ATSN-201 Shows Promise for XLRS | Image Credit: Vitreo Retinal Associates
Arshad Khanani, MD: First Results from Fellow Eye Dosing of RGX-314 in nAMD | Image Credit: Sierra Eye Associates
Jonathan Barratt, MD | Credit: IgA Nephropathy Foundation
How Artificial Intelligence is Being Used in Lung Imaging, with Rachel Eddy, PhD
Joel A. Pearlman, MD, PhD: Phase 2a Data on Oral RZ402 for DME | Image Credit: Retina Consultants Medical Group
© 2024 MJH Life Sciences

All rights reserved.